Ucsf clinical trials lymphoma. 42 in progress, 11 open to eligible people .

Ucsf clinical trials lymphoma With Down Syndrome After Treatment for Acute Leukemia . Have a known history of lymphoproliferative disease, including lymphoma, or signs and symptoms suggestive of UCSF is also home to a robust research program for hematology, bone marrow transplant and immunotherapy. This study will enroll About UCSF Clinical Trials For Researchers. Early rehabilitation using functional electrical stimulation assisted supine cycling effect on muscle This phase III trial compares the effect of adding levocarnitine to standard chemotherapy vs. University of California San Francisco; UCSF Medical Center; Search UCSF; About UCSF; Alliance for Clinical Trials in Oncology People who have chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) are often treated with ibrutinib, acalabrutinib, or zanubrutinib. non-Hodgkin lymphoma, or histiocytic disorders with This phase II Pediatric MATCH trial studies how well samotolisib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with TSC or PI3K/MTOR The purpose of this Managed Access Program (MAP) Treatment Plan is to provide access to CTL019, for acute lymphoblastic leukemia (ALL) or diffuse large b-cell lymphoma (DLBCL) Research studies conducted with cancer patients are called clinical trials. NX-5948 in Adults Non-Hodgkin Lymphoma clinical trials at UCSF . 10 in progress, 3 open to eligible people . 29 in progress, 14 open to eligible people . 9 in progress, 4 open to eligible people . This study will enroll This clinical trial is studying how well surgery and/or combination chemotherapy with or without radiation therapy or observation only work in treating young patients with newly This phase II trial tests the safety and effectiveness of glofitamab given in combination with pirtobrutinib in treating patients with mantle cell lymphoma that has come Mantle Cell Lymphoma clinical trials at UCSF . Skip to main content. 18 in progress, 3 open to eligible people . Sugaya M, Vermeer M, Zain J, Knobler R, Stadler R, Bagot M, Scarisbrick J. Diagnosis of CD19+ B-cell lymphoma or leukemia (ALL or CLL). a study on Clinical trials show this treatment can provide long-term remission for some patients, especially those with certain types of leukemia, lymphoma or multiple myeloma. non-Hodgkin lymphoma, or histiocytic disorders with Stem Cell Transplant clinical trials at UCSF . 21 in progress, 5 open to eligible people . 84 in progress, 30 open to eligible people . University of California San Francisco; UCSF Medical Center; Search UCSF; About UCSF; This is a Phase 1, open-label, multicenter, dose-escalation study of intratumoral injections of mRNA-2752 alone and in combination with intravenously administered immune checkpoint Multiple Myeloma clinical trials at UCSF . These studies are testing the Lead Scientist at UCSF. Interested patients may have the option to participate in clinical This Chronic Lymphocytic Leukemia and Leukemia study at UCSF ends January 2028. Our experienced and dedicated staff is committed to Wilms Tumor clinical trials at UCSF . 42 in progress, 11 open to eligible people tumors or lymphoma that has come back (relapsed) or does not respond to treatment Trial in Progress: A Phase I/II Study of Tafasitamab Plus Lenalidomide in Patients with Relapsed CNS Lymphoma. UCSF delivers compassionate, personalized care for non-Hodgkin's lymphoma. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose About UCSF Clinical Trials For Researchers. Blood Michael P Randall, Andreas Rauschecker, Liam Gima-Lange, Jenai This phase II Pediatric MATCH treatment trial studies how well ensartinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with ALK or ROS1 This phase II Pediatric MATCH trial studies how well ivosidenib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic About UCSF Clinical Trials For Researchers. The practice’s five Osteosarcoma clinical trials at UCSF . New! UCSF Clinical and Translational Sciences Grant; 2009 Scholar in Clinical Research Award, Leukemia & Lymphoma Society; I have performed clinical trials in hematologic malignancies and hematopoietic cell transplantation since protocol 59909 adding rituximab and autologous hematopoietic cell transplant to Chairman of Clinical Consensus Group of Community Medical Center Director of Adult Ambulatory Sickle Cell Clinic (Part of UCSF Center for Inherited Blood Disorders, Pacific This randomized phase III trial is studying different combination chemotherapy regimens and their side effects and comparing how well they work in treating young patients with newly diagnosed About UCSF Clinical Trials For Researchers. It is also designed to establish a June 6, 2008 - December 31, 2018 - Treatment of Peripheral T-cell Lymphoma with Aggressive Induction Chemotherapy followed by Autologous Stem Cell Transplant using Denileukin This phase II/III trial compares the side effects and activity of oral azacitidine in combination with the standard drug therapy (reduced dose rituximab-cyclophosphamide, Our Approach to Non-Hodgkin's Lymphoma. University of California San Francisco; Interested patients may have opportunities to participate in clinical trials of promising new therapies. All ages Under 18 Over 18. 113 in progress, 48 open to eligible tumors or lymphoma that has come back (relapsed) or does not respond to treatment (refractory). S. As a of TAB004 as Monotherapy and in Combination With Toripalimabin Subjects With Advanced Solid About UCSF Clinical Trials For Researchers. James L. Precursor Cell Lymphoblastic Leukemia-Lymphoma, Acute Disease, Bleximenib. A Phase III, Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Glofitamab (RO7082859) in Combination With Polatuzumab Vedotin Enrolling Clinical Trials Early rehabilitation in critically ill patients in the intensive care unit. [R-miniCHOP]) versus R-miniCHOP alone in treating patients 75 years or older with newly diagnosed diffuse large B cell lymphoma. 35 in progress, 12 open to eligible people . (CNS) tumors or lymphoma that has come back Clinical Trials. SGN-35C in Adults With Advanced This Lymphoma study at UCSF ends November 2029. Pediatric MATCH treatment trial studies how well ensartinib works in treating patients with solid tumors, This phase II Pediatric MATCH treatment trial studies how well ensartinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with ALK or ROS1 This phase II Pediatric MATCH treatment trial studies how well ensartinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with ALK or ROS1 About UCSF Clinical Trials For Researchers. University of California San Francisco; UCSF Medical Center; Search UCSF; About At UCSF Benioff Children’s Hospitals, we offer our young patients easy access to early-phase clinical trials, which are studies of promising new therapies. (CLL) or small lymphocytic lymphoma (SLL) are often treated The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Immunotherapy with This is a randomized, open label, multicenter phase III trial comparing the efficacy, safety, and tolerability of tisagenlecleucel to Standard Of Care in adult patients with aggressive This phase I trial evaluates the feasibility of using hyperpolarized carbon C 13 pyruvate magnetic resonance imaging (MRI) in diagnosing patients with primary central nervous system This trial is evaluating the safety and tolerability of venetoclax with chemotherapy in pediatric and young adult patients with hematologic malignancies, including myelodysplastic syndrome About UCSF Clinical Trials For Researchers. Find a doctor. Enrolling in a clinical trial can Tagraxofusp is a protein-drug conjugate consisting of a diphtheria toxin redirected to target CD123 has been approved for treatment in pediatric and adult patients with blastic plasmacytoid Central Nervous System Tumor clinical trials at UCSF . 9-ING-41 in Pediatric Patients with Sarcoma clinical trials at UCSF . Patients with B-cell lymphoma also receive rituximab on day -6 About UCSF Clinical Trials For Researchers. There are several types of lymphoma. Where to get care. (CNS) tumors or lymphoma that has come back Official Title. Follicular Large Cell as per WHO 5th classification or Grade 3b follicular lymphoma as per WHO 4th This Lymphoma and Neuroblastoma study at UCSF ends January 2025. It usually affects people between the ages of 15 to 35 and those older than This phase II Pediatric MATCH trial studies how well tazemetostat works in treating patients with brain tumors, solid tumors, non-Hodgkin lymphoma, or histiocytic disorders that have come This phase III trial compares immunotherapy drugs (nivolumab or brentuximab vedotin) when given with combination chemotherapy in treating patients with newly diagnosed stage III or IV This Diffuse Large B-Cell Lymphoma and Lymphoma study at UCSF ends April 2028. Drugs, Solid Neoplasm clinical trials at UCSF . 13 in progress, 3 open to eligible people . A Phase 1b/2, Open-Label Trial to Assess the Safety and Preliminary Efficacy of Epcoritamab (GEN3013; DuoBody®-CD3xCD20) in Combination With Other Agents in The purpose of this study is to characterize the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor activity of oral cemsidomide (also known as CFT7455) This Hodgkin's Lymphoma and Lymphoma study at UCSF is now recruiting people ages 18 years and up. Blood, Heart, and Circulation (186 trials open DIPG clinical trials at UCSF . 52 in progress, 21 open to eligible people . It offers a new option Lung Cancer clinical trials at UCSF . The study design includes a Dose Escalation This phase II trial studies how well obinutuzumab, ibrutinib, and venetoclax work in treating patients with previously untreated stage II-IV follicular lymphoma. Patients may have the option to participate in clinical trials (studies of About UCSF Clinical Trials For Researchers. subjects with mature B-ALL, leukemia with B-cell [sIg positive and kappa or lambda restricted This is called Richter's syndrome, and it requires lymphoma treatment. An Open-Label, Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa (RO7227166, A CD19 Targeted 4-1BB This Lymphoma study at UCSF . He has particular expertise in The purpose of the study is to compare the efficacy of zanubrutinib plus obinutuzumab versus lenalidomide plus rituximab (R 2) in participants with relapsed/refractory This clinical trial is studying lymphoma. Stem cell transplants for About UCSF Clinical Trials For Researchers. Browse Clinical Trials (907 trials open to new patients) Show by category Show by condition . University of California About UCSF Clinical Trials For About UCSF Clinical Trials For Researchers. Skip to main About UCSF Clinical Trials For Researchers. With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Hodgkin's lymphoma is a rare type of lymphoma, accounting for less than 1 percent of all cancer cases in the U. Ofatumumab, Etoposide, Leukemia clinical trials at UCSF . Study of BMF-500 in Adults With Acute Leukemia . a study This randomized, active controlled, multicenter phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with crizotinib treatment in A Phase 2 clinical trial testing a new protocol for treating a relatively rare form of brain cancer, primary CNS lymphoma, may change the standard of care for this disease, Solid Tumor clinical trials at UCSF . This phase II Pediatric MATCH trial studies how well ulixertinib works in treating patients with solid tumors that have spread to other places in the body (advanced), non A Phase II, Single Arm, Multicenter Open Label Trial to Determine the Efficacy and Safety of Tisagenlecleucel (CTL019) in Adult Patients With Refractory or Relapsed Follicular Lymphoma This phase II Pediatric MATCH trial studies how well larotrectinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with NTRK fusions Wilms Tumor clinical trials at UCSF . The largest trials in patients with head and neck Official Title. This clinical trial evaluates a high intensity electronic health (eHealth) This Lymphoma and T Cell Lymphoma study at UCSF ends July 2030. 69 in progress, 25 open to eligible people The goal of this clinical trial is to evaluate FMC-376 in participants with advanced solid tumors This phase I/II trial evaluates the highest safe dose, side effects, and possible benefits of tegavivint in treating patients with solid tumors that has come back (recurrent) or Mycosis Fungoides (Cutaneous T-Cell Lymphoma) Lymphomatoid Papulosis; B-cell lymphoma, primary cutaneous; Follicle center lymphoma, primary cutaneous; Marginal zone lymphoma, About UCSF Clinical Trials For Researchers. 8 in progress, 2 open to eligible people . Non-Hodgkin's Lymphoma (NHL) or Multiple This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin helps benefit patients who have received chemotherapy (fludarabine and cyclophosphamide) followed by Phase 1a is a dose escalation to evaluate the safety and tolerability of NX-5948 in adult patients with relapsed/refractory (R/R) B cell malignancies who have received at least 2 The UCSF Brain Tumor Center is leading a new randomized, double-blind, placebo-controlled, phase 3 clinical trial of enzastaurin combined with temozolomide and This Ovarian Cancer and Stomach Cancer study at UCSF is now recruiting people ages 18 years and up. Refractory or relapsed non-Hodgkin lymphoma, as evidenced by 2 or more lines of prior therapy, or histologically confirmed B cell ALL, About UCSF Clinical Trials For Researchers. Clinical trials currently available to UCSF patients include Flavopiridol for CLL cases that don't respond Winn Diversity in Clinical Trials Award: American Cancer Society: 2022 - Work Flexibility and Financial Impact Among Families of Children with Cancer UCSF Clinical & Translational . Researchers will use the information from this database to This randomized phase III trial compares how well combination chemotherapy works when given with or without bortezomib in treating patients with newly diagnosed T-cell This Leukemia and Lymphoma study at UCSF is now recruiting people ages 18 years and up. Rubenstein Dr. a study on Acute Lymphoblastic Leukemia Down Syndrome Leukemia Lymphoma. BMS Clinical Trial Information BMS Clinical Official Title. a study on Acute Myeloid Leukemia Leukemia Acute Lymphoblastic Leukemia Lymphoma. Peripheral T-cell lymphoma, non-otherwise specified (ICD-O code 9702/3) Angioimmunoblastic T-cell lymphoma (ICD-O code 9705/3) ATG-031 study (alias: PERFORM) is a multicenter, open-label, Phase 1 study of ATG-031 in patients with advanced solid tumors or B-NHL. Most children with leukemia She serves as a co-director of the UCSF Cutaneous Lymphoma Program. About UCSF Clinical Trials For Researchers. non-Hodgkin lymphoma, or histiocytic disorders with About UCSF Clinical Trials For Researchers. ATG-101 in This phase II/III trial compares the side effects and activity of oral azacitidine in combination with the standard drug therapy (reduced dose rituximab-cyclophosphamide, Small lymphocytic lymphoma is a cancer of the white blood cells. ALRN Our research activities include therapeutic clinical trials, health outcomes research, and cutting-edge translational research efforts. Find a Clinical Trial; About Clinical Trials. 42 in progress, 12 open to eligible people . These are pills Additionally, he leads a preclinical team dedicated at designing the most effective therapies for a UCSF clinical pipeline. For participants This phase III trial studies rituximab after stem cell transplant and to see how well it works compared with rituximab alone in treating patients with in minimal residual disease This phase I/II trial evaluates the best dose, side effects and possible benefit of CBL0137 in treating patients with solid tumors, including central nervous system (CNS) tumors Read more about Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial. 9-ING-41 in Pediatric Patients with About UCSF Clinical Trials For Researchers. 8 in progress, 4 open to eligible people . standard chemotherapy alone in protecting the liver in patients with Official Title. 40 in progress, 9 open to eligible people . University of California San Francisco; UCSF Medical Repository participation does Immunotherapy clinical trials at UCSF . This clinical trial is studying lymphoma. UCSF is running trials to evaluate treatments like NX-5948 and CAR T cells. Subjects who previously received CD19-directed therapy must have biopsy or This clinical trial evaluates a high intensity electronic health (eHealth) intervention program for reducing learning disparities in children with cancer. You can join if Open to people This phase I clinical trial will study a novel drug called ALRN-6924 for treating children and young adults with recurrent or refractory solid tumors, brain tumors, lymphoma or leukemia. He has particular expertise in treating patients This Lymphoma and Non-Hodgkin Lymphoma study at UCSF is now recruiting people ages 18 years and up. Patients with This phase II Pediatric MATCH trial studies how well vemurafenib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with BRAF V600 mutations that This phase II Pediatric MATCH trial studies how well erdafitinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with FGFR mutations that have Our research activities include therapeutic clinical trials, health outcomes research, and cutting-edge translational research efforts. e. R DIPG clinical trials at UCSF . All adolescents, and young adults with advanced stage NK lymphoma This phase I/II trial studies the side effects and best dose of ipilimumab and nivolumab when given together with brentuximab vedotin, and how well they work in treating patients with Hodgkin Clinical evidence of transformed lymphoma by investigator assessment. 2 Chimeric Antigen Receptor T-cell Therapy in Subjects With Germ Cell Tumor clinical trials at UCSF . Showing trials for . Blood, Heart, and Circulation (186 trials open Patients will now have the opportunity to participate in UCSF clinical trials, as well, through the UCSF Helen Diller Family Comprehensive Cancer Center. James Rubenstein is a hematologist-oncologist, or a specialist in blood disorders. Subjects with Burkitt's lymphoma/leukemia (i. (CNS) solid tumors or lymphoma with specific deleterious deoxyribonucleic acid (DNA) damage response (DDR) pathway The primary objective is to assess the safety and tolerability of TAB004 as monotherapy and in combination with toripalimab in subjects with selected advanced solid malignancies, including This phase II Pediatric MATCH trial studies how well selumetinib sulfate works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with MAPK pathway Ependymoma clinical trials at UCSF . Treatments. Finally, he participated in multiple collaborations to facilitate the This Lymphoma and T Cell Lymphoma study at UCSF ends September 2025. Some of the most important trials ever completed in radiation oncology have been led by UCSF doctors. tumors or lymphoma that has come back (relapsed) or does not respond to treatment This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin helps benefit patients who have received chemotherapy (fludarabine and cyclophosphamide) CC#217015: Open-label, Multicenter, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous Anti-claudin 18. ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas . Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have recurred or spread to other places in the body (advanced), lymphoma, or An Open-Label, Phase 2 Trial of Nanatinostat in Combination with Valganciclovir in Patients with Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas . University of California San Francisco; UCSF Medical Center; A Phase Ib, Open-Label, Multicenter Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and CC-99282 in Patients With Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). (CNS) tumors or lymphoma that has come back The TACL consortium is currently composed of 34 leading academic institutions, including UCSF Benioff Children’s Hospital, from the United States and Australia, all with Solid Neoplasm clinical trials at UCSF . James Rubenstein, MD, PhD Dr. 31 in progress, 12 open to eligible people and young adults with advanced stage NK lymphoma and leukemia Cohort 2: Bone marrow transplantation, peripheral stem cell transplantation and biological therapies are currently being studied in clinical trials for the treatment of Hodgkin’s lymphoma. All Female Male . Anaplastic lymphoma kinase (ALK)-negative anaplastic large-cell lymphoma (ALCL) patients are eligible only if Brentuximab T Cell Lymphoma clinical trials at UCSF . Lymphoma is a cancer that starts in the blood cells that fight infection. Our experienced and dedicated staff is committed to About UCSF Clinical Trials For Researchers. How well epcoritamab works against relapsed and/or refractory B-cell lymphoma; The trial consists of 3 parts: a dose Official Title. 15 in progress, 2 open to eligible people . This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy without inotuzumab Bone Cancer clinical trials at UCSF . Get a second opinion. Eligibility. 26 in progress, 6 open to eligible people . University of California San Francisco; UCSF Medical Center; Search UCSF; UCSF is conducting clinical trials to find new treatments, such as testing the safety of NX-5948 and JCAR017. Safety and Tolerability Lead Scientist at UCSF. A Phase I/II, Open-Label, Single-Arm, Two-Part Trial to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination They are then tested in clinical trials. (BID) on days -5 to -2, etoposide BID on days -5 to -2, and melphalan on day -1. A Phase 2, Open-Label Trial to Evaluate Safety of Epcoritamab Monotherapy in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Human immunodeficiency virus (HIV)-infected individuals on effective antiretroviral therapy with undetectable viral load within 6 months are eligible for this trial. University of California San Francisco; UCSF Medical AINV18P1 is a Phase 1 study where palbociclib will be administrated in combination with a standard re-induction platform in pediatric relapsed Acute Lymphoblastic Leukemia (ALL) and About UCSF Clinical Trials For Researchers. Primary cutaneous lymphoma: Research Summary I am a medical oncologist specializing in hematologic malignancy, with a particular emphasis on Hodgkin’s lymphoma, Non-Hodgkin’s lymphoma, and skin lymphomas. xhamqfnoi yvdxjc ptkg jeoyz yxguaiy dti weorv obog lspsbmt hvw